nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Cladribine—NR5A1—ovarian cancer	0.0254	1	CrCbGaD
Abacavir—ADK—myometrium—ovarian cancer	0.0067	0.145	CbGeAlD
Abacavir—ADK—uterine cervix—ovarian cancer	0.00521	0.113	CbGeAlD
Abacavir—ADK—decidua—ovarian cancer	0.00497	0.108	CbGeAlD
Abacavir—ADK—endometrium—ovarian cancer	0.00472	0.102	CbGeAlD
Abacavir—ADK—gonad—ovarian cancer	0.00437	0.0949	CbGeAlD
Abacavir—ADK—female reproductive system—ovarian cancer	0.00391	0.0847	CbGeAlD
Abacavir—ADK—bone marrow—ovarian cancer	0.00369	0.08	CbGeAlD
Abacavir—ADK—female gonad—ovarian cancer	0.00355	0.0771	CbGeAlD
Abacavir—ADK—vagina—ovarian cancer	0.00353	0.0766	CbGeAlD
Abacavir—ADK—testis—ovarian cancer	0.00315	0.0684	CbGeAlD
Abacavir—ADK—lymph node—ovarian cancer	0.00228	0.0496	CbGeAlD
Abacavir—Diarrhoea—Melphalan—ovarian cancer	0.00114	0.00123	CcSEcCtD
Abacavir—Nausea—Chlorambucil—ovarian cancer	0.00114	0.00123	CcSEcCtD
Abacavir—Dizziness—Topotecan—ovarian cancer	0.00113	0.00122	CcSEcCtD
Abacavir—Migraine—Epirubicin—ovarian cancer	0.00113	0.00121	CcSEcCtD
Abacavir—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00112	0.0012	CcSEcCtD
Abacavir—Anaemia—Paclitaxel—ovarian cancer	0.00111	0.0012	CcSEcCtD
Abacavir—Erythema multiforme—Docetaxel—ovarian cancer	0.00111	0.00119	CcSEcCtD
Abacavir—Vomiting—Topotecan—ovarian cancer	0.00109	0.00117	CcSEcCtD
Abacavir—Malaise—Paclitaxel—ovarian cancer	0.00109	0.00117	CcSEcCtD
Abacavir—Vertigo—Paclitaxel—ovarian cancer	0.00108	0.00117	CcSEcCtD
Abacavir—Lethargy—Doxorubicin—ovarian cancer	0.00108	0.00116	CcSEcCtD
Abacavir—Leukopenia—Paclitaxel—ovarian cancer	0.00108	0.00116	CcSEcCtD
Abacavir—Rash—Topotecan—ovarian cancer	0.00108	0.00116	CcSEcCtD
Abacavir—Hypersensitivity—Vinorelbine—ovarian cancer	0.00108	0.00116	CcSEcCtD
Abacavir—Dermatitis—Topotecan—ovarian cancer	0.00108	0.00116	CcSEcCtD
Abacavir—Blood creatinine increased—Epirubicin—ovarian cancer	0.00107	0.00115	CcSEcCtD
Abacavir—Headache—Topotecan—ovarian cancer	0.00107	0.00115	CcSEcCtD
Abacavir—Vomiting—Melphalan—ovarian cancer	0.00106	0.00115	CcSEcCtD
Abacavir—Immune system disorder—Docetaxel—ovarian cancer	0.00106	0.00114	CcSEcCtD
Abacavir—Liver function test abnormal—Epirubicin—ovarian cancer	0.00106	0.00114	CcSEcCtD
Abacavir—Rash—Melphalan—ovarian cancer	0.00105	0.00114	CcSEcCtD
Abacavir—Dermatitis—Melphalan—ovarian cancer	0.00105	0.00114	CcSEcCtD
Abacavir—Chills—Docetaxel—ovarian cancer	0.00105	0.00113	CcSEcCtD
Abacavir—Cough—Paclitaxel—ovarian cancer	0.00105	0.00113	CcSEcCtD
Abacavir—Asthenia—Vinorelbine—ovarian cancer	0.00105	0.00113	CcSEcCtD
Abacavir—Abdominal pain upper—Epirubicin—ovarian cancer	0.00104	0.00112	CcSEcCtD
Abacavir—Convulsion—Paclitaxel—ovarian cancer	0.00104	0.00112	CcSEcCtD
Abacavir—Migraine—Doxorubicin—ovarian cancer	0.00104	0.00112	CcSEcCtD
Abacavir—Alopecia—Docetaxel—ovarian cancer	0.00104	0.00112	CcSEcCtD
Abacavir—Pruritus—Vinorelbine—ovarian cancer	0.00103	0.00111	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00103	0.00111	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00103	0.00111	CcSEcCtD
Abacavir—Arthralgia—Paclitaxel—ovarian cancer	0.00103	0.0011	CcSEcCtD
Abacavir—Myalgia—Paclitaxel—ovarian cancer	0.00103	0.0011	CcSEcCtD
Abacavir—Anxiety—Paclitaxel—ovarian cancer	0.00102	0.0011	CcSEcCtD
Abacavir—Malnutrition—Docetaxel—ovarian cancer	0.00102	0.0011	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00102	0.0011	CcSEcCtD
Abacavir—Nausea—Topotecan—ovarian cancer	0.00101	0.00109	CcSEcCtD
Abacavir—Discomfort—Paclitaxel—ovarian cancer	0.00101	0.00109	CcSEcCtD
Abacavir—Gastritis—Epirubicin—ovarian cancer	0.00101	0.00109	CcSEcCtD
Abacavir—Muscular weakness—Epirubicin—ovarian cancer	0.00101	0.00109	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.00101	0.00109	CcSEcCtD
Abacavir—Diarrhoea—Vinorelbine—ovarian cancer	0.001	0.00108	CcSEcCtD
Abacavir—Nausea—Melphalan—ovarian cancer	0.000994	0.00107	CcSEcCtD
Abacavir—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000991	0.00107	CcSEcCtD
Abacavir—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000983	0.00106	CcSEcCtD
Abacavir—Oedema—Paclitaxel—ovarian cancer	0.000983	0.00106	CcSEcCtD
Abacavir—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000977	0.00105	CcSEcCtD
Abacavir—Infection—Paclitaxel—ovarian cancer	0.000977	0.00105	CcSEcCtD
Abacavir—Pancreatitis—Epirubicin—ovarian cancer	0.000969	0.00104	CcSEcCtD
Abacavir—Dizziness—Vinorelbine—ovarian cancer	0.000967	0.00104	CcSEcCtD
Abacavir—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000966	0.00104	CcSEcCtD
Abacavir—Nervous system disorder—Paclitaxel—ovarian cancer	0.000964	0.00104	CcSEcCtD
Abacavir—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000963	0.00104	CcSEcCtD
Abacavir—Skin disorder—Paclitaxel—ovarian cancer	0.000955	0.00103	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000953	0.00103	CcSEcCtD
Abacavir—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000953	0.00103	CcSEcCtD
Abacavir—Bronchitis—Epirubicin—ovarian cancer	0.000951	0.00102	CcSEcCtD
Abacavir—Anaemia—Docetaxel—ovarian cancer	0.000944	0.00102	CcSEcCtD
Abacavir—Anorexia—Paclitaxel—ovarian cancer	0.000937	0.00101	CcSEcCtD
Abacavir—Gastritis—Doxorubicin—ovarian cancer	0.000936	0.00101	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000933	0.00101	CcSEcCtD
Abacavir—Muscular weakness—Doxorubicin—ovarian cancer	0.000933	0.00101	CcSEcCtD
Abacavir—Vomiting—Vinorelbine—ovarian cancer	0.000929	0.001	CcSEcCtD
Abacavir—Neutropenia—Epirubicin—ovarian cancer	0.000924	0.000995	CcSEcCtD
Abacavir—Rash—Vinorelbine—ovarian cancer	0.000922	0.000993	CcSEcCtD
Abacavir—Dermatitis—Vinorelbine—ovarian cancer	0.000921	0.000992	CcSEcCtD
Abacavir—Hypotension—Paclitaxel—ovarian cancer	0.000919	0.000989	CcSEcCtD
Abacavir—Headache—Vinorelbine—ovarian cancer	0.000916	0.000986	CcSEcCtD
Abacavir—Leukopenia—Docetaxel—ovarian cancer	0.000914	0.000984	CcSEcCtD
Abacavir—Pancreatitis—Doxorubicin—ovarian cancer	0.000897	0.000966	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000896	0.000965	CcSEcCtD
Abacavir—Hyperglycaemia—Epirubicin—ovarian cancer	0.000892	0.00096	CcSEcCtD
Abacavir—Cough—Docetaxel—ovarian cancer	0.000891	0.00096	CcSEcCtD
Abacavir—Insomnia—Paclitaxel—ovarian cancer	0.000889	0.000958	CcSEcCtD
Abacavir—Pneumonia—Epirubicin—ovarian cancer	0.000886	0.000955	CcSEcCtD
Abacavir—Convulsion—Docetaxel—ovarian cancer	0.000885	0.000953	CcSEcCtD
Abacavir—Paraesthesia—Paclitaxel—ovarian cancer	0.000883	0.000951	CcSEcCtD
Abacavir—Bronchitis—Doxorubicin—ovarian cancer	0.00088	0.000947	CcSEcCtD
Abacavir—Dyspnoea—Paclitaxel—ovarian cancer	0.000877	0.000944	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000874	0.000941	CcSEcCtD
Abacavir—Arthralgia—Docetaxel—ovarian cancer	0.000869	0.000936	CcSEcCtD
Abacavir—Myalgia—Docetaxel—ovarian cancer	0.000869	0.000936	CcSEcCtD
Abacavir—Nausea—Vinorelbine—ovarian cancer	0.000868	0.000935	CcSEcCtD
Abacavir—Renal failure—Epirubicin—ovarian cancer	0.000866	0.000933	CcSEcCtD
Abacavir—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000864	0.00093	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000863	0.00093	CcSEcCtD
Abacavir—Stomatitis—Epirubicin—ovarian cancer	0.000859	0.000925	CcSEcCtD
Abacavir—Conjunctivitis—Epirubicin—ovarian cancer	0.000857	0.000923	CcSEcCtD
Abacavir—Neutropenia—Doxorubicin—ovarian cancer	0.000855	0.000921	CcSEcCtD
Abacavir—Decreased appetite—Paclitaxel—ovarian cancer	0.000855	0.00092	CcSEcCtD
Abacavir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000849	0.000914	CcSEcCtD
Abacavir—Fatigue—Paclitaxel—ovarian cancer	0.000848	0.000913	CcSEcCtD
Abacavir—Pain—Paclitaxel—ovarian cancer	0.000841	0.000905	CcSEcCtD
Abacavir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000833	0.000898	CcSEcCtD
Abacavir—Anaphylactic shock—Docetaxel—ovarian cancer	0.000833	0.000897	CcSEcCtD
Abacavir—Oedema—Docetaxel—ovarian cancer	0.000833	0.000897	CcSEcCtD
Abacavir—Infection—Docetaxel—ovarian cancer	0.000828	0.000892	CcSEcCtD
Abacavir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000825	0.000888	CcSEcCtD
Abacavir—Pneumonia—Doxorubicin—ovarian cancer	0.00082	0.000883	CcSEcCtD
Abacavir—Nervous system disorder—Docetaxel—ovarian cancer	0.000817	0.00088	CcSEcCtD
Abacavir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000816	0.000879	CcSEcCtD
Abacavir—Feeling abnormal—Paclitaxel—ovarian cancer	0.00081	0.000873	CcSEcCtD
Abacavir—Skin disorder—Docetaxel—ovarian cancer	0.000809	0.000872	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000808	0.000871	CcSEcCtD
Abacavir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000804	0.000866	CcSEcCtD
Abacavir—Renal failure—Doxorubicin—ovarian cancer	0.000802	0.000863	CcSEcCtD
Abacavir—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000799	0.000861	CcSEcCtD
Abacavir—Stomatitis—Doxorubicin—ovarian cancer	0.000795	0.000856	CcSEcCtD
Abacavir—Anorexia—Docetaxel—ovarian cancer	0.000794	0.000855	CcSEcCtD
Abacavir—Conjunctivitis—Doxorubicin—ovarian cancer	0.000793	0.000854	CcSEcCtD
Abacavir—Hepatitis—Epirubicin—ovarian cancer	0.000791	0.000852	CcSEcCtD
Abacavir—Pharyngitis—Epirubicin—ovarian cancer	0.000785	0.000846	CcSEcCtD
Abacavir—Urticaria—Paclitaxel—ovarian cancer	0.000781	0.000841	CcSEcCtD
Abacavir—Hypotension—Docetaxel—ovarian cancer	0.000779	0.000839	CcSEcCtD
Abacavir—Connective tissue disorder—Epirubicin—ovarian cancer	0.000777	0.000837	CcSEcCtD
Abacavir—Body temperature increased—Paclitaxel—ovarian cancer	0.000777	0.000837	CcSEcCtD
Abacavir—Abdominal pain—Paclitaxel—ovarian cancer	0.000777	0.000837	CcSEcCtD
Abacavir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000771	0.000831	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000759	0.000818	CcSEcCtD
Abacavir—Insomnia—Docetaxel—ovarian cancer	0.000754	0.000812	CcSEcCtD
Abacavir—Paraesthesia—Docetaxel—ovarian cancer	0.000748	0.000806	CcSEcCtD
Abacavir—Erythema multiforme—Epirubicin—ovarian cancer	0.000748	0.000806	CcSEcCtD
Abacavir—Dyspnoea—Docetaxel—ovarian cancer	0.000743	0.0008	CcSEcCtD
Abacavir—Hepatitis—Doxorubicin—ovarian cancer	0.000732	0.000788	CcSEcCtD
Abacavir—Pharyngitis—Doxorubicin—ovarian cancer	0.000727	0.000782	CcSEcCtD
Abacavir—Decreased appetite—Docetaxel—ovarian cancer	0.000724	0.00078	CcSEcCtD
Abacavir—Hypersensitivity—Paclitaxel—ovarian cancer	0.000724	0.00078	CcSEcCtD
Abacavir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000719	0.000775	CcSEcCtD
Abacavir—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000719	0.000775	CcSEcCtD
Abacavir—Fatigue—Docetaxel—ovarian cancer	0.000718	0.000774	CcSEcCtD
Abacavir—Immune system disorder—Epirubicin—ovarian cancer	0.000715	0.00077	CcSEcCtD
Abacavir—Pain—Docetaxel—ovarian cancer	0.000713	0.000767	CcSEcCtD
Abacavir—Chills—Epirubicin—ovarian cancer	0.00071	0.000764	CcSEcCtD
Abacavir—Asthenia—Paclitaxel—ovarian cancer	0.000705	0.00076	CcSEcCtD
Abacavir—Alopecia—Epirubicin—ovarian cancer	0.000699	0.000753	CcSEcCtD
Abacavir—Pruritus—Paclitaxel—ovarian cancer	0.000696	0.000749	CcSEcCtD
Abacavir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000692	0.000745	CcSEcCtD
Abacavir—Malnutrition—Epirubicin—ovarian cancer	0.000689	0.000742	CcSEcCtD
Abacavir—Feeling abnormal—Docetaxel—ovarian cancer	0.000687	0.00074	CcSEcCtD
Abacavir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000681	0.000734	CcSEcCtD
Abacavir—Diarrhoea—Paclitaxel—ovarian cancer	0.000673	0.000724	CcSEcCtD
Abacavir—Immune system disorder—Doxorubicin—ovarian cancer	0.000661	0.000712	CcSEcCtD
Abacavir—Abdominal pain—Docetaxel—ovarian cancer	0.000659	0.000709	CcSEcCtD
Abacavir—Body temperature increased—Docetaxel—ovarian cancer	0.000659	0.000709	CcSEcCtD
Abacavir—Chills—Doxorubicin—ovarian cancer	0.000657	0.000707	CcSEcCtD
Abacavir—Dizziness—Paclitaxel—ovarian cancer	0.00065	0.0007	CcSEcCtD
Abacavir—Alopecia—Doxorubicin—ovarian cancer	0.000647	0.000697	CcSEcCtD
Abacavir—Ill-defined disorder—Epirubicin—ovarian cancer	0.000639	0.000688	CcSEcCtD
Abacavir—Malnutrition—Doxorubicin—ovarian cancer	0.000637	0.000686	CcSEcCtD
Abacavir—Anaemia—Epirubicin—ovarian cancer	0.000637	0.000686	CcSEcCtD
Abacavir—Vomiting—Paclitaxel—ovarian cancer	0.000625	0.000673	CcSEcCtD
Abacavir—Malaise—Epirubicin—ovarian cancer	0.000621	0.000669	CcSEcCtD
Abacavir—Rash—Paclitaxel—ovarian cancer	0.00062	0.000668	CcSEcCtD
Abacavir—Dermatitis—Paclitaxel—ovarian cancer	0.000619	0.000667	CcSEcCtD
Abacavir—Vertigo—Epirubicin—ovarian cancer	0.000619	0.000666	CcSEcCtD
Abacavir—Leukopenia—Epirubicin—ovarian cancer	0.000616	0.000664	CcSEcCtD
Abacavir—Headache—Paclitaxel—ovarian cancer	0.000616	0.000663	CcSEcCtD
Abacavir—Hypersensitivity—Docetaxel—ovarian cancer	0.000614	0.000661	CcSEcCtD
Abacavir—Cough—Epirubicin—ovarian cancer	0.000601	0.000647	CcSEcCtD
Abacavir—Asthenia—Docetaxel—ovarian cancer	0.000598	0.000644	CcSEcCtD
Abacavir—Convulsion—Epirubicin—ovarian cancer	0.000597	0.000643	CcSEcCtD
Abacavir—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000591	0.000637	CcSEcCtD
Abacavir—Pruritus—Docetaxel—ovarian cancer	0.00059	0.000635	CcSEcCtD
Abacavir—Anaemia—Doxorubicin—ovarian cancer	0.000589	0.000634	CcSEcCtD
Abacavir—Arthralgia—Epirubicin—ovarian cancer	0.000586	0.000631	CcSEcCtD
Abacavir—Myalgia—Epirubicin—ovarian cancer	0.000586	0.000631	CcSEcCtD
Abacavir—Anxiety—Epirubicin—ovarian cancer	0.000584	0.000629	CcSEcCtD
Abacavir—Nausea—Paclitaxel—ovarian cancer	0.000584	0.000629	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000582	0.000627	CcSEcCtD
Abacavir—Discomfort—Epirubicin—ovarian cancer	0.000579	0.000624	CcSEcCtD
Abacavir—Malaise—Doxorubicin—ovarian cancer	0.000575	0.000619	CcSEcCtD
Abacavir—Vertigo—Doxorubicin—ovarian cancer	0.000573	0.000617	CcSEcCtD
Abacavir—Leukopenia—Doxorubicin—ovarian cancer	0.00057	0.000614	CcSEcCtD
Abacavir—Diarrhoea—Docetaxel—ovarian cancer	0.00057	0.000614	CcSEcCtD
Abacavir—Anaphylactic shock—Epirubicin—ovarian cancer	0.000562	0.000605	CcSEcCtD
Abacavir—Oedema—Epirubicin—ovarian cancer	0.000562	0.000605	CcSEcCtD
Abacavir—Infection—Epirubicin—ovarian cancer	0.000558	0.000601	CcSEcCtD
Abacavir—Cough—Doxorubicin—ovarian cancer	0.000556	0.000599	CcSEcCtD
Abacavir—Convulsion—Doxorubicin—ovarian cancer	0.000552	0.000595	CcSEcCtD
Abacavir—Nervous system disorder—Epirubicin—ovarian cancer	0.000551	0.000594	CcSEcCtD
Abacavir—Dizziness—Docetaxel—ovarian cancer	0.000551	0.000593	CcSEcCtD
Abacavir—Thrombocytopenia—Epirubicin—ovarian cancer	0.00055	0.000593	CcSEcCtD
Abacavir—Skin disorder—Epirubicin—ovarian cancer	0.000546	0.000588	CcSEcCtD
Abacavir—Arthralgia—Doxorubicin—ovarian cancer	0.000543	0.000584	CcSEcCtD
Abacavir—Myalgia—Doxorubicin—ovarian cancer	0.000543	0.000584	CcSEcCtD
Abacavir—Anxiety—Doxorubicin—ovarian cancer	0.000541	0.000582	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000539	0.00058	CcSEcCtD
Abacavir—Discomfort—Doxorubicin—ovarian cancer	0.000536	0.000577	CcSEcCtD
Abacavir—Anorexia—Epirubicin—ovarian cancer	0.000536	0.000577	CcSEcCtD
Abacavir—Vomiting—Docetaxel—ovarian cancer	0.00053	0.000571	CcSEcCtD
Abacavir—Rash—Docetaxel—ovarian cancer	0.000525	0.000566	CcSEcCtD
Abacavir—Hypotension—Epirubicin—ovarian cancer	0.000525	0.000566	CcSEcCtD
Abacavir—Dermatitis—Docetaxel—ovarian cancer	0.000525	0.000565	CcSEcCtD
Abacavir—Headache—Docetaxel—ovarian cancer	0.000522	0.000562	CcSEcCtD
Abacavir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00052	0.00056	CcSEcCtD
Abacavir—Oedema—Doxorubicin—ovarian cancer	0.00052	0.00056	CcSEcCtD
Abacavir—Infection—Doxorubicin—ovarian cancer	0.000517	0.000556	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000512	0.000552	CcSEcCtD
Abacavir—Nervous system disorder—Doxorubicin—ovarian cancer	0.00051	0.000549	CcSEcCtD
Abacavir—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000509	0.000548	CcSEcCtD
Abacavir—Insomnia—Epirubicin—ovarian cancer	0.000508	0.000547	CcSEcCtD
Abacavir—Skin disorder—Doxorubicin—ovarian cancer	0.000505	0.000544	CcSEcCtD
Abacavir—Paraesthesia—Epirubicin—ovarian cancer	0.000505	0.000544	CcSEcCtD
Abacavir—Dyspnoea—Epirubicin—ovarian cancer	0.000501	0.00054	CcSEcCtD
Abacavir—Anorexia—Doxorubicin—ovarian cancer	0.000496	0.000534	CcSEcCtD
Abacavir—Nausea—Docetaxel—ovarian cancer	0.000495	0.000533	CcSEcCtD
Abacavir—Decreased appetite—Epirubicin—ovarian cancer	0.000489	0.000526	CcSEcCtD
Abacavir—Hypotension—Doxorubicin—ovarian cancer	0.000486	0.000523	CcSEcCtD
Abacavir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000485	0.000523	CcSEcCtD
Abacavir—Fatigue—Epirubicin—ovarian cancer	0.000485	0.000522	CcSEcCtD
Abacavir—Pain—Epirubicin—ovarian cancer	0.000481	0.000518	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000474	0.00051	CcSEcCtD
Abacavir—Insomnia—Doxorubicin—ovarian cancer	0.00047	0.000507	CcSEcCtD
Abacavir—Paraesthesia—Doxorubicin—ovarian cancer	0.000467	0.000503	CcSEcCtD
Abacavir—Dyspnoea—Doxorubicin—ovarian cancer	0.000464	0.000499	CcSEcCtD
Abacavir—Feeling abnormal—Epirubicin—ovarian cancer	0.000463	0.000499	CcSEcCtD
Abacavir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00046	0.000495	CcSEcCtD
Abacavir—Decreased appetite—Doxorubicin—ovarian cancer	0.000452	0.000487	CcSEcCtD
Abacavir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000449	0.000484	CcSEcCtD
Abacavir—Fatigue—Doxorubicin—ovarian cancer	0.000448	0.000483	CcSEcCtD
Abacavir—Urticaria—Epirubicin—ovarian cancer	0.000447	0.000481	CcSEcCtD
Abacavir—Pain—Doxorubicin—ovarian cancer	0.000445	0.000479	CcSEcCtD
Abacavir—Body temperature increased—Epirubicin—ovarian cancer	0.000444	0.000479	CcSEcCtD
Abacavir—Abdominal pain—Epirubicin—ovarian cancer	0.000444	0.000479	CcSEcCtD
Abacavir—Feeling abnormal—Doxorubicin—ovarian cancer	0.000429	0.000462	CcSEcCtD
Abacavir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000425	0.000458	CcSEcCtD
Abacavir—Hypersensitivity—Epirubicin—ovarian cancer	0.000414	0.000446	CcSEcCtD
Abacavir—Urticaria—Doxorubicin—ovarian cancer	0.000413	0.000445	CcSEcCtD
Abacavir—Body temperature increased—Doxorubicin—ovarian cancer	0.000411	0.000443	CcSEcCtD
Abacavir—Abdominal pain—Doxorubicin—ovarian cancer	0.000411	0.000443	CcSEcCtD
Abacavir—Asthenia—Epirubicin—ovarian cancer	0.000403	0.000434	CcSEcCtD
Abacavir—Pruritus—Epirubicin—ovarian cancer	0.000398	0.000428	CcSEcCtD
Abacavir—Diarrhoea—Epirubicin—ovarian cancer	0.000385	0.000414	CcSEcCtD
Abacavir—Hypersensitivity—Doxorubicin—ovarian cancer	0.000383	0.000413	CcSEcCtD
Abacavir—Asthenia—Doxorubicin—ovarian cancer	0.000373	0.000402	CcSEcCtD
Abacavir—Dizziness—Epirubicin—ovarian cancer	0.000372	0.0004	CcSEcCtD
Abacavir—Pruritus—Doxorubicin—ovarian cancer	0.000368	0.000396	CcSEcCtD
Abacavir—Vomiting—Epirubicin—ovarian cancer	0.000357	0.000385	CcSEcCtD
Abacavir—Diarrhoea—Doxorubicin—ovarian cancer	0.000356	0.000383	CcSEcCtD
Abacavir—Rash—Epirubicin—ovarian cancer	0.000354	0.000382	CcSEcCtD
Abacavir—Dermatitis—Epirubicin—ovarian cancer	0.000354	0.000381	CcSEcCtD
Abacavir—Headache—Epirubicin—ovarian cancer	0.000352	0.000379	CcSEcCtD
Abacavir—Dizziness—Doxorubicin—ovarian cancer	0.000344	0.00037	CcSEcCtD
Abacavir—Nausea—Epirubicin—ovarian cancer	0.000334	0.00036	CcSEcCtD
Abacavir—Vomiting—Doxorubicin—ovarian cancer	0.000331	0.000356	CcSEcCtD
Abacavir—Rash—Doxorubicin—ovarian cancer	0.000328	0.000353	CcSEcCtD
Abacavir—Dermatitis—Doxorubicin—ovarian cancer	0.000328	0.000353	CcSEcCtD
Abacavir—Headache—Doxorubicin—ovarian cancer	0.000326	0.000351	CcSEcCtD
Abacavir—Nausea—Doxorubicin—ovarian cancer	0.000309	0.000333	CcSEcCtD
